Jeffrey B Landau Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Jeffrey B Landau is Chief Business Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 119,056 shares of CTMX, which is worth approximately $126,199. The most recent transaction as insider was on Aug 20, 2024, when has been sold 4,181 shares (Common Stock) at a price of $1.23 per share, resulting in proceeds of $5,142. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
119K
0%
3M change
31.26%
12M change
Total Value Held
$126,199
Jeffrey B Landau Transaction History
JBL
Jeffrey B Landau
Chief Business Officer
South San Francisco, CA